(最近の論文)

1.	Kato S, Gold BD, Kato A. Gastrointestinal manifestations and pathogenesis in childhood immunoglobulin A vasculitis. Front Pediatr 12: 1459394, 2024 IgA血管炎とその亜型と報告したIgA腸症の消化管病変を詳細に論説し、さらに、現在のIgA血管炎の診断基準について修正を提案した。
2.	Kato S, Gold BD, Kato A. Helicobacter pylori-associated iron deficiency anemia in childhood and adolescence: Pathogenesis and clinical management strategies. J Clin Med 11: 7351, 2022 H. pyloriによる鉄欠乏性貧血の病態や治療戦略などを論説した。
3.	Kato S, Gold BD, Kato A. The resolution of severe iron-deficiency anemia after successful eradication of Helicobacter pylori in teenagers. JPGN Rep 3: 3(e238), 2022 難治性・再発性の鉄欠乏性貧血にH. pyloriが関与していること、また除菌により治癒することを、長期の経過観察により報告した。
4.	Kato S, Shimizu T, Toyoda S, et al. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int 62: 1315-31,2020 小児期のH. pylori感染症のガイドライン（改定2版）を日本小児栄養消化器肝臓学会として英文で公表した。
5.	Kato S, et al. Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence. PLoS One 12: e0184046, 2017 H. pyloriは鉄欠乏性貧血を起こすが、その関連遺伝子を世界で初めて同定した。

(国際委員会報告)

6.	Spolidoro JV, Kay M, Ament M, Cadranel S, Fujimoto T, Gilger M, Kato S, et al. New endoscopic and diagnostic techniques: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2002
7.	Drumm B, Day AS, Gold B, Gottrand F, Kato S, et al. Helicobacter pylori and peptic ulcer: Working group report of the 2nd world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr 2004
8.	Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, et al. A global evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009.

(栄養学・代謝)

9.	Igarashi Y, Kato S, et al. A direct evidence for defect in G6P transport system in hepatic microsomal membrane of glycogen storage disease type Ib. Biochem Biophys Res Commun 1984
10.	Igarashi Y, Kato S, et al. Kinetic properties of the G6P transport system in rat hepatic microsomal membranes. J Inher Metab Dis 1985
11.	Tada K, Narisawa K, Igarashi Y, Kato S. Glycogen storage disease type IB: A new model of genetic disorders involving the transport system of intracellular membrane. Biochem Med 1985
12.	Igarashi Y, Kato S, et al. Kinetic studies of the glucose-6 phosphate transport system in rat hepatic microsomal membrane. J Inher Metab Dis 1986
13.	Kuramoto Y, Igarashi Y, Kato S, et al. Aquired zinc deficiency in two breast-fed mature infants. Acta Derm Venereol 1986
14.	Kurobane I, Inoue S, Gotoh Y, Kato S, et al. Biochemical improvement after treatment by bone marrow transplantation in I-cell disease. Tohoku J Exp Med 1986
15.	Hayasaka K, Narisawa K, Saito T, Numakura H, Fukuda K, Kato S, et al. Treatment of cystinosis: Decrease in content of free cystine in leukocytes and alleviation of progressive renal failure by treatment with riboflavin. Act Paediatr Jpn 1986
16.	Hayasaka K, Metoki K, Ishiguro S, Kato S, et al. Partial ornithine transcarbamylase deficiency in females: diagnosis by an immunohistochemical method. Eur J Pediatr 1987
17.	Kure S, Sato K, Fujii K, Aoki Y, Suzuki Y, Kato S, et al. Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metabolism 2004

（小児消化管内視鏡検査）

18.	Kato S, et al.: A clinical study of gastrointestinal endoscopy in Japanese children. Acta Paediatr Jpn 33:36-42, 1991
19	Kato S, et al. Gastrointestinal endoscopy in Henoch-Schönlein purpura. Eur J Pediatr1992
20	Kato S, et al. Endoscopic ultrasonography in a child with chronic pancreatitis. Acta Paediatr Jpn 1993
21	Kato S, et al. Endoscopic ethanol injection for treatment of bleeding peptic ulcer. Eur J Pediatr 153:873-5, 1994
22	Ebina K, Kato S, et al. Endoscopic hemostasis of bleeding duodenal ulcer in a child with Henoch-Schönlein purpura. J Pediatr 1997
23	Kato S, et al. Endoscopic hemostasis of bleeding duodenal ulcer in a child with Henoch-Schönlein purpura (reply). J Pediatr 1998
24	Kato S, et al. A new developed small-caliber videoduodenoscope for endoscopic retrograde cholangiopancreatography in children. J Clin Gastroenterol 2003

（小児消化性潰瘍など消化管疾患）

25	Kato S, et al. Doxycycline-induced hemorrhagic esophagitis: a pediatric case. J Pediatr Gastroenterol Nutr 1988
26	Kato S, et al. Locations of peptic ulcers in children. Gastroenterol Jpn 1989
27	Kato S, et al. Gastric acid secretion in a child with postbulbar duodenal ulcer.Gastroenterol Jpn 1989
28	Kato S, et al. Chronic pancreatitis in muscular cytochrome c oxidase deficiency. J Pediatr Gastroenterol Nutr 1990
29	Kato S, et al. Medication-induced esophagitis in children. Gastroenterol Jpn 1990
30	Kato S, et al. Pharmacokinetic study of cimetidine in pediatric duodenal ulcer. Clin Ther 1991
31	Kato S, et al. Pyloric narrowing with increased fibrous tissue of the mucosa in an infant. Tohoku J Exp Med 1991
32	Kato S, et al. Effectiveness and pharmacokinetics of omeprazole in children with refractory duodenal ulcer. J Pediatr Gastroenterol Nutr 1992
33	Kato S, et al. Inflammatory esophagogastric polyp and fold in an adolescent. Acta Paediatr Jpn 1993
34	Kato S, et al. Efficacy of twice-daily cimetidine in pediatric peptic ulcer. J Pediatr Gastroenterol Nutr 1994
35	Kato S, et al. The effects of omeprazole on the ultrastructure of gastric parietal cells. J Pediatr Gastroenterol Nutr 1994
36	Kato S, et al. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and 24-hour intragastric acidity. J Pediatr 1996
37	Kato S, et al. Ruby laser therapy for labial lentigines in Peutz-Jeghers syndrome. Eur J Pediatr 1998.
38	Kato S, et al. Intestinal IgA deposition in Henoch-Schönlein purpura with severe GI manifestations. Eur J Pediatr 1996
39	Kato S, et al. Immunoglobulin A enteropathy: a possible variant of Henoch-Schoenlein purpura. Dig Dis Sci 2004

（ピロリ菌感染症）

40	Kato S, et al. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. Pediatrics 1997
41	Kato S, et al. Helicobacter pylori reinfection rates in children after eradication therapy. J Pediatr Gastroenterol Nutr 1998
42	Kato S, et al. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. Helicobacter 1998
43	Kato S, et al. Long-term follow-up study of serum IgG and IgA antibodies after Helicobacter pylori eradication. Pediatrics 1999
44	Kato S, et al. CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease. J Clin Microbiol 2000
45	Kato S, et al. Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics 2001
46	Yosjimura N, Tajiri H, Sawada A, Kozaiwa K, Ida S, Fujisawa T, Konno M, Kato S. A 13C-urea breath test in children with Helicobacter pylori infection: assessment of eradication therapy ad follow-up after treatment. J Gastroenterol 2001
47	Kato S, et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002.
48	Fujimura S, Kato S, et al.: In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. J Antimicrob Chemother 2002
49	Kato S, et al. Diagnostic accuracy of 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol 2002
50	Fujimura S, Kato S, et al.: Influence of rifampicin on Helicobacter pylori prevalence in patients with mycobacterial infection. Eur J Gastroenterol Hepatol 2002
51	Fujimura S, Kawamura T, Kato S, et al.: Detection of Helicobacter pylori in cow's milk. Lett Appl Microbiol 2002
52	Kato S, et al. Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection. A multicenter Japanese study. Am J Gastroenterol 2003
53	Kato S, et al. Helicobacter pylori and TT virus in Japanese children. J Gastroenterol 2003
54	Minoura T, Kato S, et al. Childhood Helicobacter pylori infection: Maternal transmission and eradication by systemic immunization using bacterial antigen-aluminium hydroxide. Clin Exp Immunol 2003
55	Fujimura S, Kato S, et al.: In vitro exposure to macrolide antibiotics inHelicobacter pylori strains isolated from children. J Infect Chemother 10:128-30, 2004
56	Kato S, et al. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children. Helicobacter 2004
57	Fujimura S, Kato S, et al. Helicobacter pylori in natural environmental water in Japan. Lett Appl Microbiol 2004
58	Azuma T, Kato S, et al.: The diversity of vacA and cagA genes of Helicobacter pylori in Japanese children. Aliment Pharmacol Ther 2004
59	Kato S, et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol 2004
60	Kato S, et al. Results of triple eradication therapy in Japanese children. J Gastroenterol 2004
61	Kato S, et al. A comparisons between the 13C-urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. J Gastroenterol 2004
62	Fujimura S, Kato S, et al. The Detection of Helicobacter pylori in the stools of newborn infants. Pediatr Infect Dis J 2004
63	Fujimura S, Kato S, et al. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. J Med Microbiol 2004
64	Kato S, et al. Multicenter comparison of rapid lateral flow stool antigen immunoassay and stool antigen EIA for the diagnosis of Helicobacter pylori infection in children. Helicobacter 2004
65	Minoura T, Kato S, et al. Influence of age and infection period on inflammatory and immune responses to Helicobacter pylori infection in a murine model. Clin Exp Immunol 2005
66	Ozawa K, Kato S, et al. Gastric epithelial cell turnover and mucosal protection in Japanese children with Helicobacter pylori infection. J Gastroenterol 2005
67	Fujimura S, Kato S, et al. In vitro activity of tetracyclines against Helicobacter pylori isolates from Japanese children. Pediatr Infect Dis J 2005
68	Kato S, et al. Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. J Gastroenterol 2005
69	Kato S, Sherman PM. What is new related to Helicobacter pylori infection in children and teenagers? Arch Pediatr Adolesc Med 2005
70	Kato S, et al. Association between gastric atrophy and Helicobacter pylori infection in Japanese children: a retrospective multicenter study. Dig Dis Sci 2006
71	Kato S, et al. Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci 2006
72	Fujimura S, Kato S, et al. Detection of Lactobacillus gasserri OLL2176 strain administered with Yogurt drink in gastric mucus layer in human. Lett Appl Microbiol 2006
73	Kobayashi I, Murakami K, Kato M, Kato S, et al. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol 2007
74	Fujimura S, Kato S, et al. Water source as a Helicobacter pylori transmission route: a 3-year follow-up study of Japanese children living in a unique distinct. J Med Microbiol 2008
75	Kato S, et al. When does gastric atrophy develop in Japanese children? Helicobacter 2008
76	Kato S, et al. Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. Pediatr Int 2010

（病原性大腸菌O157感染、その他）

77	Naganuma H, Kyogoku M, Abe J, Fukui K, Inoue S, Yamamoto K, Kato S, et al. An autopsy case of Kawasaki disease with reference to occurrence of acute coronary thrombosis in the convalescent stage. Acta Pathol Jpn 1992
78	Kato S, et al. Antibiotic-associated hemorrhagic colitis without Clostridium difficile toxin in children. J Pediatr 1995
79	Yamamoto K, Takayanagi M, Yoshihara Y, Murata Y, Kato S, et al. Acute disseminated encephalomyelitis associated with Mycoplasma pneumoniae infection. Acta Paediatr Jpn 1995
80	Fujimura S, Kato S, et al. Survey of methicillin-resistant Staphylococcus aureus from neonates and the environment in the NICU. J Infect Chemother 2004
81	Jandu N, Ceponis PJM, Kato S, et al.: Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator transcription (STAT)-1 activation by interferon-β. Infct Immun 2006

(学会ガイドライン)